← Shelf·Delta Sleep-Inducing Peptide (nonapeptide)·XXX.
DSIP.
A nine-amino-acid peptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated by Marcel Monnier's group at the University of Basel in the mid-1970s, from cerebral venous blood of rabbits during electrically-induced delta-wave EEG sleep. Never developed as a pharmaceutical; remains a research-only compound.
DSIP is endogenous to mammalian brain tissue. Whether it functions physiologically as a sleep regulator, a stress modulator, or something else has been debated in the neuropeptide literature for five decades without a resolved answer.
Sold with sleep-improvement and stress-recovery framing the primary literature has not established. DSIP has been researched continuously since the 1970s — and continuously failed to produce the clinical results early proponents expected. Interesting biology, unresolved therapeutic story.
Straight talk
Straight talk: DSIP is one of the longer-studied compounds in this catalog and one of the more inconclusive. Fifty years of experimental work, mostly small-scale, in vitro and animal, with occasional human studies of modest quality. If a compound were going to prove itself for consumer sleep applications, five decades of research is enough time. It has not.
What the research studies
The literature, not a summary of it.
Foundational isolation: Monnier and Schoenenberger at Basel. Ongoing biology work: Kovalzon, Prinz. Journals: Neurosci Biobehav Rev, Peptides, Sleep, Biol Chem. Read the research yourself:
Recommended vendor · Amino Club
≥ 99% by HPLC on the current lot — ILS Laboratories (ISO/IEC 17025).
$14.99 with Club pricing (was $29.99)
35% off applied automatically at checkout when you land through this link.
Related on the shelf